Medical research

FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month to prove if it really can fend off the coronavirus, its manufacturer announced Thursday, June 11 -- a long-awaited step in the global vaccine race. The vaccine, developed by the U.S. National Institutes of Health and Moderna Inc., will be tested in 30,000 volunteers -- some given the real shot and some a dummy shot. (AP Photo/Ted S. Warren, File)
June 11, 2020 - 2:16 pm
The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month to prove if it really can fend off the coronavirus, while hard-hit Brazil is testing a different shot from China. Where to do crucial, late-stage testing and how many volunteers are needed to roll up...
Read More
This undated photo provided courtesy of Anisha Khanna, shows, from left, Anisha, Sughanda, Kamlesh, Satyender and Priya Khanna. The northern New Jersey family of five doctors has lost two members to COVID-19. Satyender Khanna, who died at 77, was a practicing surgeon for more than four decades. His daughter, Priya Khanna, who died at 43, specialized in the study of kidney diseases.  (Courtesy of Anisha Khanna via AP)
June 09, 2020 - 1:01 am
NEW YORK (AP) — Priya Khanna may have been destined to practice medicine all along, and not necessarily because she grew up in a family of doctors. The middle daughter of a surgeon and pediatrician who had immigrated from India and settled in northern New Jersey in the early 1970s, Khanna tested...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
June 05, 2020 - 12:34 pm
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More
FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
June 04, 2020 - 5:20 pm
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. Thursday’s retraction in the journal Lancet...
Read More
FILE - In this April 6, 2020 file photo, a pharmacist holds a bottle of the drug hydroxychloroquine in Oakland, Calif. Results published Wednesday, June 3, 2020, by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the COVID-19 coronavirus. The drug did not seem to cause serious harm, though - about 40% on it had side effects, mostly mild stomach problems. (AP Photo/Ben Margot)
June 03, 2020 - 5:07 pm
A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease. Results published Wednesday by the New England Journal of Medicine show that...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Tuesday, June 2, 2020, concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. (AP Photo/John Locher,File)
June 02, 2020 - 4:06 pm
Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. The New England Journal of Medicine issued an “ expression of concern ” Tuesday on a study it published May 1...
Read More
Matt Hancock Britain's Secretary of State for Health is driven through the entrance to Parliament in London, Tuesday, June 2, 2020. The British government has decided to scrap a remote-voting system used during the coronavirus pandemic, and has summoned lawmakers back to parliament on Tuesday, but many aren't happy with the arrangements. (AP Photo/Frank Augstein)
June 02, 2020 - 2:03 pm
LONDON (AP) — People from ethnic minorities have died from COVID-19 in larger relative numbers in England than their white compatriots, according to a study published by health authorities Tuesday. The Public Health England report hinted at reasons for the discrepancy but didn't offer any...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday, June 1, 2020, but said full results would soon be published in a medical journal. (AP Photo/Ben Margot, File)
June 01, 2020 - 11:53 am
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday but said full results would soon be published in a medical journal. Remdesivir is the only...
Read More
A traveler passes a sign recommending practicing social distancing, to limit spread of the coronavirus outbreak, at the nearly passenger-less JetBlue terminal at Logan Airport in Boston, Friday, May 29, 2020. (AP Photo/Charles Krupa)
May 29, 2020 - 2:48 pm
NEW YORK (AP) — The spark that started the U.S. coronavirus epidemic arrived during a three-week window from mid-January to early February, before the nation halted travel from China, according to the most comprehensive federal study to date of when the virus began spreading. That means anyone in...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
May 29, 2020 - 8:32 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More

Pages